Skip to main content

Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure

Publication ,  Journal Article
Gibb, AA; Murray, EK; Huynh, AT; Gaspar, RB; Ploesch, TL; Bedi, K; Lombardi, AA; Lorkiewicz, PK; Roy, R; Arany, Z; Kelly, DP; Margulies, KB ...
Published in: Circulation
May 24, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

May 24, 2022

Volume

145

Issue

21

Start / End Page

1625 / 1628

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gibb, A. A., Murray, E. K., Huynh, A. T., Gaspar, R. B., Ploesch, T. L., Bedi, K., … Elrod, J. W. (2022). Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure. Circulation, 145(21), 1625–1628. https://doi.org/10.1161/circulationaha.121.057879
Gibb, Andrew A., Emma K. Murray, Anh T. Huynh, Ryan B. Gaspar, Tori L. Ploesch, Ken Bedi, Alyssa A. Lombardi, et al. “Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure.” Circulation 145, no. 21 (May 24, 2022): 1625–28. https://doi.org/10.1161/circulationaha.121.057879.
Gibb AA, Murray EK, Huynh AT, Gaspar RB, Ploesch TL, Bedi K, et al. Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure. Circulation. 2022 May 24;145(21):1625–8.
Gibb, Andrew A., et al. “Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure.” Circulation, vol. 145, no. 21, Ovid Technologies (Wolters Kluwer Health), May 2022, pp. 1625–28. Crossref, doi:10.1161/circulationaha.121.057879.
Gibb AA, Murray EK, Huynh AT, Gaspar RB, Ploesch TL, Bedi K, Lombardi AA, Lorkiewicz PK, Roy R, Arany Z, Kelly DP, Margulies KB, Hill BG, Elrod JW. Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure. Circulation. Ovid Technologies (Wolters Kluwer Health); 2022 May 24;145(21):1625–1628.

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

May 24, 2022

Volume

145

Issue

21

Start / End Page

1625 / 1628

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology